Literature DB >> 3943451

Sclerosing hepatitis and azathioprine.

J A Barrowman, P K Kutty, M U Ra, S N Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3943451     DOI： 10.1007/bf01300713

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

1.  HEPATOTOXICITY OF MERCAPTOPURINE.

Authors:  M EINHORN; I DAVIDSOHN
Journal:  JAMA       Date:  1964-06-01       Impact factor: 56.272

2.  Irreversible liver damage after azathioprine.

Authors:  Z Zarday; F J Veith; M L Gliedman; R Soberman
Journal:  JAMA       Date:  1972-11-06       Impact factor: 56.272

3.  Etiology of liver disease in renal-transplant patients.

Authors:  A J Ware; J P Luby; B Hollinger; E H Eigenbrodt; J A Cuthbert; C R Atkins; J Shorey; A R Hull; B Combes
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

4.  Intrahepatic cholestasis due to azathioprine.

Authors:  M Sparberg; N Simon; F del Greco
Journal:  Gastroenterology       Date:  1969-10       Impact factor: 22.682

5.  Treatment of psoriasis with azathioprine.

Authors:  A Du Vivier; D D Munro; J Verbov
Journal:  Br Med J       Date:  1974-01-12

6.  Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans.

Authors:  R A DePinho; C S Goldberg; J H Lefkowitch
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682
  6 in total
  2 in total

1.  Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis.

Authors:  F Mion; B Napoleon; F Berger; M Chevallier; S Bonvoisin; L Descos
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

Review 2.  Hepatotoxicity Secondary to Chemotherapy.

Authors:  Alla Grigorian; Christopher B O'Brien
Journal:  J Clin Transl Hepatol       Date:  2014-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.